Fritextsökning
Innehållstyper
- 
                                The US is leaving the WHOThe newly installed US President, Donald Trump, has issued an executive order for the US to leave the World Health Organization, WHO. 
- 
                                Samuel Lagercrantz: “Companies that do this successfully will take the lead”The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r... 
- 
                                Explore the latest trends and innovations in quality assurance and manufacturingZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024. 
- 
                                Oavbrutet flöde med SMC:s nya clamp-on flödesmätareSMC lanserar en clamp-on flödesmätare för vätska och stärker därmed positionen som innovativ aktör inom industriell automation världen över. 
- 
                                Her company is developing a new tablet form obesity drugObesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi... 
- 
                                40,000 DNA extractions dailyIt's great when things run quickly: 20 minutes per extraction process and a new plate every 2.5 minutes – the Dutch company Synchron Lab Automation, in cooperat... 
- 
                                From Valneva to the CEO position at NorthX – “I saw it as a great opportunity”A new cell therapy for leukaemia, a vaccine in tablet form against cholera, and a proprietary mRNA line with the potential capacity to supply the entire Nordic ... 
- 
                                CROs in drug development: "We use our expertise to speed up the processConsultancy firms have become an increasingly important part of drug development. “It’s a trend and a business model that works, and we see no indication that i... 
- 
                                The life science strategy – what the industry wantsThe process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe... 
- 
                                ZEISS receives FDA clearance for INTRABEAM 700With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro tumor therapy. 
- 
                                Come see us at the upcoming events!We have some upcoming events where you can see our latest products live! 
- 
                                Johan Pehrson takes over the responsibility for research policy in SwedenThe Liberals' party leader Johan Pehrson takes over the assignment as Minister for Education. This was announced by Prime Minister Ulf Kristersson (M) on Tuesday last week. 
- 
                                Revealing the secrets of a partCT inspection in automation technology at Festo. 
- 
                                Innovative start-up helps doctors, scientists and industry balance coagulation risksFor many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thro... 
- 
                                Join the premier metrology and quality assurance event of the yearZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024. 
- 
                                “Don’t postpone the transition to IVDR”Operators who have not yet started to adapt to the requirements of the new EU IVDR regulation are running out of excuses. This is the opinion of Helena Dzojic, ... 
- 
                                It couldn’t be simplerAI-assisted ZEISS Solution inspects implant coatings automatically. 
- 
                                Spatial Biology Studies in Lung Tissue using Spectral MicroscopySpectral imaging with the ZEISS LSM 980 laser scanning confocal enables more complex studies of cell-cell interactions and locations in immunology research. 
- 
                                Webinar: Support Trial Patients Transitioning to the Commercial SpaceRegister for expert insights on supporting Phase III clinical trial patients post-approval and read our blog on advanced Patient Assistance Programs. 
- 
                                Explore 3D Testing of Deformation and MotionsPowerful measurement capabilities with the new ZEISS ARAMIS 1. 
- 
                                ”Information security must become part of the Swedish life science strategy”Sweden needs knowledge security to stand strong in the global competition, writes Björn Ursing in an opinion article. 
- 
                                Here are the pharmaceutical companies best prepared for AIHow well prepared are pharmaceutical companies in the field of artificial intelligence? That is what a new analysis has tried to evaluate. 
- 
                                Elevating 3D characterization with enhanced performance and efficienciesIntroducing the ZEISS VersaXRM 730 3D X-ray microscope. 
- 
                                Xbrane enters licensing agreement with Indian generics giantSwedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.